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Cardiac resynchronisation therapy (CRT) is a recognised therapy for the management of
severe left ventricular dysfunction, advanced congestive cardiac failure (NYHA III or IV),
ventricular dyssynchrony (either broad LBBB or mechanical dyssynchrony on echocardi-
ography) and failure of optimal medical therapy to achieve improvement in clinical status.
Upgrading right ventricular pacemakers or defibrillators to biventricular devices is com-
mon and we describe here, 2 such cases of biventricular upgrade with blocked venous
access on the ipsilateral side and successful placement of left ventricular leads following
pre-sternal tunnelling from the contralateral side.
Copyright © 2015, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
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Cardiac resynchronisation therapy (CRT) is a recognised
therapy for the management of severe left ventricular
dysfunction, advanced congestive cardiac failure (NYHA III or
IV), ventricular dyssynchrony (either broad LBBB or mechan-
ical dyssynchrony on echocardiography) and failure of
optimal medical therapy to achieve improvement in clinical
status [1]. Upgrading right ventricular pacemakers or de-
fibrillators to biventricular devices is common practice andwe
describe here, 2 such cases of biventricular upgrade with
blocked venous access on the ipsilateral side and successfuliology, Northampton Gen
.nhs.uk (J. Timperley).
eart Rhythm Society.
ythm Society. Production
mons.org/licenses/by-ncplacement of left ventricular leads following pre-sternal
tunnelling from the contralateral side.
Our first patient was a 65 year old gentleman with a
background of ischaemic cardiomyopathy and percutaneous
coronary intervention (PCI) to his left anterior descending
artery in 2006. A secondary prevention implantable car-
dioverter defibrillator (ICD) (St Jude Atlas DR) was inserted on
the left side in 2004 for monomorphic ventricular tachycardia
(VT). He required subsequent extraction due to pocket erosion
and a new systemwas implanted on the right side. His clinical
status deteriorated in the following years with NYHA class III
heart failure, severe LV dysfunction (LVEF 30%) and broad
LBBB (130 ms) despite optimal medical treatment and theeral Hospital, Northampton NN1 9BD, United Kingdom. Tel.: þ44
and hosting by Elsevier B.V. This is an open access article under
-nd/4.0/).
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previous device procedures, we undertook contrast venog-
raphy to study the upper limb venous anatomy which
confirmed occlusion of the right subclavian vein (Fig. 1).
The second patient was a 78 year old gentleman with
ischaemic cardiomyopathy and LVEF of 18%. His background
included moderate-severe COPD, multi-nodular goitre and
post-vagotomy dumping syndrome. He had a primary pre-
vention ICD (Medtronic Marquis 7274 device with OptiVol
Sensor) and his clinical status had deteriorated over the years
necessitating upgrade to CRT-D. Despite optimal medical
therapy, he had NYHA class III heart failure, broad QRS
duration (150 ms) and his device had detected an increase in
the intrathroacic pressure (Optivol fluid index >200 and
thoracic impedance <70 U) supporting the clinical diagnosis of
deteriorating heart failure. Venogram through the left anti-
cubital vein showed a short occlusion of the left subclavian
vein (Fig. 1). The procedure was initially attempted on the left,
with successful cannulation of the left subclavian vein but
unable to advance the guidewire to the superior vena cava
(SVC). The procedurewas abandoned and CRT-D implantation
was performed on the right.
Both procedures were performed under general anaes-
thesia. For the first patient with blocked right subclavian vein,
a left extra-thoracic subclavian puncture was made under
fluoroscopic guidance and a small pocket was formed in the
prepectoral area. The coronary sinus (CS) was cannulated and
a Starfix LV lead was placed in mid-position of a large ante-
rolateral vein with satisfactory parameters (R wave 11.1 mV,
impedance 556U and threshold 0.8 V @ 0.4ms). For the second
patient, left extra-thoracic subclavian vein was used. The CS
was cannulated with a Multipurpose catheter and a Starfix LV
lead was placed in the middle branch of the three antero-
lateral branches with satisfactory position and lead parame-
ters (threshold 0.7 V @ 0.5 ms, impedance 840 U and R wave of
11.2 mV).
In both cases, the following technique was employed
(Fig. 2): A Baird single lumen Groshong central line kit wasFig. 1 e Venogram showing blocked subclused. This has a soft, silicone tubing with a closed rounded tip
and comes complete with a metal tunnelling device. The
closed end of the tubing is excised leaving a double ended
silicone tube. One end is pushed onto the rear end of the
tunneller and the other end onto the IS-1 connector of the LV
lead. The diameter of the Groshong line is a perfect fit for the
IS-1 connector. The tunneller is then pushed through the
subcutaneous tissue in front of the chest to the contralateral
pocket pulling the LV lead IS-1 connector. The diameter of the
tunneller is such that the lead pulls freely through the tissue.
The lead is then connected to the new CRT-D and the wounds
closed with standard technique. A small loop of lead is left in
the small pocket side of the venous puncture and the LV lead
then secured to the pectoral muscle. Finally, the old device
was explanted and the lead parameters checked on the
existing leads.
Post-procedure chest X-ray (CXR) confirmed good lead po-
sition and no pneumothorax (Fig. 3). At 6 months and 1 year
follow-up, there was a significant clinical improvement of
heart failure, no procedure related complications and func-
tioning LV lead with stable parameters (Patient 1 LV lead pa-
rameters at 6 months: R wave 9.9 mV, Impedance 492 U and
threshold 0.9 V @ 0.4 ms; and R wave 11.1 mV, Impedance
556 U and threshold 0.8 V @ 0.4ms at 1 year), (Patient 2 LV lead
parameters: R wave 11.9 mV, Impedance 627 U and threshold
0.5 V @ 0.4 ms at 6 months and R wave of 10.5 mV, Impedance
532 U and threshold 0.75 V @ 0.4 ms at 1 year).Discussion
The number of complex device (ICD and CRT-P/D) implanta-
tions has significantly increased in the last decade [2,3]. Not
only has the number of new device implantations gone up,
also has the number of upgrades either from a pacemaker
(PPM) to ICD/CRT or from ICD to CRT-P/CRT-D. Data from the
REPLACE registry shows that patients undergoing replace-
ment of a chronically implanted pacemaker or ICD areavian vein in patient 1 and patient 2.
Fig. 2 e Groshong Central line kit used for the procedure.
Fig. 3 e CXR post-implantation in patient 1 and patient 2.
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tions if a transvenous lead is added to replace a defect elec-
trode or for device upgrade [4]. Of relevance to our patients is
the occlusion of the ipsilateral subclavian vein which is not anuncommon finding and previous authors have reported up to
25% of patients needing lead revision or device upgrade [5,6].
Many alternative routes have been proposed for such a
situation: (1) puncture of the ipsilateral subclavian or
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 1 1 3e1 1 7116brachiocepahlic vein proximal (or medial) to the site of
obstruction, with or without a supraclavicular approach with
subcutaneous tunnelling [7]; (2) Ovadia et al. [8] describe a
percutaneous brachiocephalic (innominate) or deep subcla-
vian venous access by a supraclavicular approach using an 18-
gauge Deseret angiocath, a Terumo Glidewire, and dilation to
permit one or two 9e11 Fr sheaths, followed by tunnelling of
electrodes (pre or retroclavicularly) to a pre or retropectoral
pocket; (3) Aleksic et al. [9] describe the ‘notch technique’ to
puncture of the contralateral innominate vein (with subcu-
taneous tunnelling) e an 18F needle was introduced 1 cm
above the sternoclavicular joint palpable as a notch and
angled at 45 to puncture the innominate vein at 3e4 cm
depth. A 8.5F percutaneous sheath introducer set (Arrow In-
ternational Inc) was used and electrode placed with over the
wire technique and lead brought back to the original pocket;
(4) puncture of the ipsilateral jugular vein from the neck (with
subcutaneous tunnelling of the lead) is described by Bosa-
Odeja et al. [10] Seldinger technique was used to puncture
the jugular vein and a 0.38 inch Teflon guidewire was
advanced through the needle to the right ventricle and was
replaced with an 8F sheath to continue the procedure in the
standard fashion. The lead and the protective sheath were
secured to the muscle layers in the clavicular portion of ster-
nocleidomastoid muscle; (5) extraction of the defect lead with
ipsilateral implantation of a new transvenous electrode [11];
(6) transatrial or epicardial lead placement [12,13]; (7) contra-
lateral implantation of the complete systemwith explantation
or abandoning of the old leads [14]; (8) Fox et al. [16] describe
the procedure using a pair of long forceps and blunt dissection
to create a subcutaneous tract from the right to the left. The
proximal end of the LV lead was grasped with the forceps and
tunnelled above the sternum to rejoin the pocket; and (9)
Another technique not widely practised currently is the
placement of transvenous electrode from the contralateral
side with sub-cutaneous, pre-sternal lead tunnelling. Luthje
et al. [15] described using regular chest tube and a trochar for
this technique, and passing the lead in the chest tube to the
other end. This procedure is more invasive and involves both
the cardiologist and the cardio-thoracic surgeon and is not
currently favoured.
Our technique is different andmuch simpler than the ones
described requiring a single operator and a widely available
kit. However, more data is needed to assess long term feasi-
bility, safety and reliability before it can be recommended on a
universal basis. Because no general recommendations exist
currently, the individual choice between the different ap-
proaches largely depend on individual operator experience,
the indication for lead implantation, patient characteristics,
and the resulting riskebenefit ratio. Our technique adds
another potential option to patients with limited venous
access.Conflict of interest
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